Identifiers
Functions
Ganoderma Lucidum Ferment is a triterpenoid-containing ingredient derived from Ganoderma lucidum, and its primary documented role is as a source of ganoderic acid A, a bioactive triterpenoid. In applications where it is used, it functions as a functional ingredient delivering this compound. However, the available evidence does not specify particular product categories, formulation roles, or mechanisms of action beyond the presence of ganoderic acid A. Researchers should treat its application roles as undetermined until further data on its functional or sensory contributions are available.
The evidence does not identify a specific product or formulation problem that Ganoderma Lucidum Ferment solves. The only documented attribute is that it contains ganoderic acid A, a triterpenoid, which may be relevant for formulations targeting bioactivity associated with this compound. However, without data on its solubility, stability, or interaction with other ingredients, no formulation problem—such as preservation, texture, or delivery—can be confirmed. Researchers should not assume a problem-solving role without additional evidence.
The main commercial or clinical use of Ganoderma Lucidum Ferment is not supported by direct evidence in the available data. The only relevant finding is that ganoderic acid A, a triterpenoid, has been reported in Ganoderma lucidum and other species, and its structure has been isolated from this source. This establishes the compound's presence but does not substantiate any specific commercial or clinical application. Researchers should seek additional clinical or market data to validate any claimed uses.
No formulation trade-offs can be identified from the available evidence. The data only confirms that Ganoderma Lucidum Ferment contains ganoderic acid A, a triterpenoid, but provides no information on its physicochemical properties, stability, compatibility, or sensory impact. Without such data, researchers cannot assess trade-offs like solubility, pH sensitivity, or interaction with other ingredients. Further characterization is required before formulation decisions can be made.
| Property | Value | Category |
|---|---|---|
| XLogP3 | 2.2 | Computed Molecular Properties |
| Exact Mass | 516.30870374 | Computed Molecular Properties |
| Monoisotopic Mass | 516.30870374 | Computed Molecular Properties |
| Topological Polar Surface Area | 129.0 | Computed Molecular Properties |
| Complexity | 1070.0 | Computed Molecular Properties |
| Hydrogen Bond Donor Count | 3 | Computed Molecular Properties |
| Hydrogen Bond Acceptor Count | 7 | Computed Molecular Properties |
| Rotatable Bond Count | 6 | Computed Molecular Properties |
| Heavy Atom Count | 37 | Computed Molecular Properties |
| Formal Charge | 0 | Computed Molecular Properties |